Your browser doesn't support javascript.
loading
Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis.
Chikhoune, Liticia; Brousseau, Thierry; Morell-Dubois, Sandrine; Farhat, Meryem Maud; Maillard, Helene; Ledoult, Emmanuel; Lambert, Marc; Yelnik, Cecile; Sanges, Sebastien; Sobanski, Vincent; Hachulla, Eric; Launay, David.
Afiliação
  • Chikhoune L; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.
  • Brousseau T; CHU Lille, Service de Biochimie Automatisée Protéines, F-59000 Lille, France.
  • Morell-Dubois S; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.
  • Farhat MM; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.
  • Maillard H; U1286-INFINITE-Institute for Translational Research in Inflammation, Université de Lille, F-59000 Lille, France.
  • Ledoult E; Inserm, F-59000 Lille, France.
  • Lambert M; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.
  • Yelnik C; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.
  • Sanges S; U1286-INFINITE-Institute for Translational Research in Inflammation, Université de Lille, F-59000 Lille, France.
  • Sobanski V; Inserm, F-59000 Lille, France.
  • Hachulla E; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.
  • Launay D; CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000 Lille, France.
J Clin Med ; 11(17)2022 Aug 30.
Article em En | MEDLINE | ID: mdl-36079017
ABSTRACT
(1)

Background:

Systemic sclerosis (SSc) is a heterogeneous connective tissue disease with a high mortality and morbidity rate. Identification of biomarkers that can predict the evolution of SSc is a key factor in the management of patients. The aim of this study was to assess the association of routine laboratory parameters, widely used in practice and easily available, with the severity and progression of SSc. (2)

Methods:

In this retrospective monocentric cohort study, 372 SSc patients were included. We gathered clinical and laboratory data including routine laboratory parameters C-reactive-protein (CRP), erythrocyte sedimentation rate (ESR), complete blood count, serum sodium and potassium levels, creatinin, urea, ferritin, albumin, uric acid, N-terminal pro-brain natriuretic peptide (NTproBNP), serum protein electrophoresis, and liver enzymes. Associations between these routine laboratory parameters and clinical presentation and outcome were assessed. (3)

Results:

Median (interquartile range) age was 59.0 (50.0; 68.0) years. White blood cell, monocyte, and neutrophil absolute counts were significantly higher in patients with diffuse cutaneous SSc and with interstitial lung disease (ILD) (p < 0.001). CRP was significantly higher in patients with ILD (p < 0.001). Hemoglobin and ferritin were significantly lower in patients with pulmonary hypertension (PH) including pulmonary arterial hypertension and ILD associated PH (p = 0.016 and 0.046, respectively). Uric acid and NT pro BNP were significantly higher in patients with PH (<0.001). Monocyte count was associated with ILD progression over time. (4)

Conclusions:

Overall, our study highlights the association of routine laboratory parameters used in current practice with the severity and progression of SSc.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França